Article info

Original research
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma

Authors

  1. Correspondence to Dr Amir A Jazaeri; AAJazaeri{at}mdanderson.org
View Full Text

Citation

Amaria R, Knisely A, Vining D, et al
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma

Publication history

  • Accepted January 9, 2024
  • First published February 2, 2024.
Online issue publication 
March 29, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.